Market Closed -
Bombay S.E.
11:00:47 14/05/2024 BST
|
5-day change
|
1st Jan Change
|
1,917
INR
|
+0.60%
|
|
+0.86%
|
+17.61%
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,312
|
1,253
|
3,725
|
21,906
|
17,104
|
Enterprise Value (EV)
1 |
2,742
|
2,856
|
5,361
|
23,692
|
20,337
|
P/E ratio
|
11
x
|
10.5
x
|
17.3
x
|
40.7
x
|
25.2
x
|
Yield
|
-
|
-
|
0.15%
|
0.03%
|
0.03%
|
Capitalization / Revenue
|
0.39
x
|
0.42
x
|
1.04
x
|
3.58
x
|
2.55
x
|
EV / Revenue
|
0.81
x
|
0.96
x
|
1.49
x
|
3.87
x
|
3.03
x
|
EV / EBITDA
|
7.79
x
|
7.79
x
|
10.9
x
|
25.5
x
|
17.9
x
|
EV / FCF
|
-25.5
x
|
-12.9
x
|
407
x
|
-39.3
x
|
-15.3
x
|
FCF Yield
|
-3.93%
|
-7.76%
|
0.25%
|
-2.55%
|
-6.52%
|
Price to Book
|
2.87
x
|
2.17
x
|
4.72
x
|
12.7
x
|
7.19
x
|
Nbr of stocks (in thousands)
|
10,899
|
10,899
|
10,899
|
11,399
|
11,399
|
Reference price
2 |
120.4
|
115.0
|
341.8
|
1,922
|
1,500
|
Announcement Date
|
17/07/19
|
07/07/20
|
25/06/21
|
20/06/22
|
20/06/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,498
|
3,401
|
2,971
|
3,594
|
6,127
|
6,716
|
EBITDA
1 |
268.7
|
351.9
|
366.7
|
490
|
929.7
|
1,134
|
EBIT
1 |
211.8
|
292.3
|
291.5
|
370.1
|
742.9
|
951.4
|
Operating Margin
|
8.48%
|
8.59%
|
9.81%
|
10.3%
|
12.13%
|
14.17%
|
Earnings before Tax (EBT)
1 |
102
|
167.9
|
168.6
|
306.9
|
708.4
|
906
|
Net income
1 |
79.71
|
118.9
|
119.9
|
214.8
|
522.9
|
678.7
|
Net margin
|
3.19%
|
3.5%
|
4.04%
|
5.98%
|
8.53%
|
10.11%
|
EPS
2 |
7.963
|
10.91
|
11.00
|
19.71
|
47.25
|
59.54
|
Free Cash Flow
1 |
-253.5
|
-107.7
|
-221.6
|
13.17
|
-603.1
|
-1,327
|
FCF margin
|
-10.15%
|
-3.17%
|
-7.46%
|
0.37%
|
-9.84%
|
-19.76%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
2.69%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
6.13%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.5000
|
0.5000
|
0.5000
|
Announcement Date
|
09/07/18
|
17/07/19
|
07/07/20
|
25/06/21
|
20/06/22
|
20/06/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,367
|
1,430
|
1,603
|
1,636
|
1,786
|
3,233
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.089
x
|
4.063
x
|
4.371
x
|
3.338
x
|
1.921
x
|
2.851
x
|
Free Cash Flow
1 |
-254
|
-108
|
-222
|
13.2
|
-603
|
-1,327
|
ROE (net income / shareholders' equity)
|
31.2%
|
29.8%
|
23.1%
|
31.5%
|
41.5%
|
33%
|
ROA (Net income/ Total Assets)
|
6.45%
|
7.58%
|
6.95%
|
7.94%
|
11.8%
|
10.5%
|
Assets
1 |
1,235
|
1,568
|
1,725
|
2,706
|
4,437
|
6,465
|
Book Value Per Share
2 |
31.10
|
42.00
|
53.00
|
72.40
|
152.0
|
209.0
|
Cash Flow per Share
2 |
15.00
|
6.910
|
7.680
|
0.6000
|
0.1900
|
0.4600
|
Capex
1 |
172
|
341
|
279
|
140
|
568
|
1,481
|
Capex / Sales
|
6.88%
|
10.03%
|
9.39%
|
3.89%
|
9.27%
|
22.05%
|
Announcement Date
|
09/07/18
|
17/07/19
|
07/07/20
|
25/06/21
|
20/06/22
|
20/06/23
|
|
1st Jan change
|
Capi.
|
---|
| +17.61% | 260M | | +16.79% | 66.18B | | +1.64% | 49.24B | | +16.70% | 41.72B | | +22.44% | 26.16B | | +12.92% | 19.75B | | +2.96% | 17.5B | | -23.54% | 15.63B | | -6.28% | 15.46B | | +2.52% | 15.43B |
Other Specialty Chemicals
|